Theriva Biologics
TOVX
TOVX
18 hedge funds and large institutions have $1.01M invested in Theriva Biologics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
UBS Group
Zurich,
Switzerland
|
$5.93K |
2 |
2
Renaissance Technologies
New York
|
$39K |
3 |
3
Morgan Stanley
New York
|
$12 |